Aim Performance of Glypican-3 (GPC3)-targeted photoimmunotherapy (PIT) combined with the nanoparticle albumin-bound paclitaxel (nab-paclitaxel) for hepatocellular carcinoma was evaluated. with new culture medium comprising 10 μg/ml of IR700-YP7 and incubated for 6 h at 37°C. After washing with PBS PBS was added again. Then cells were irradiated with NIR light at 16 J/cm2. Cells incubated… Continue reading Aim Performance of Glypican-3 (GPC3)-targeted photoimmunotherapy (PIT) combined with the nanoparticle